Tezepelumab Pharmacokinetics, Safety, and Tolerability After Administration via Vial-and-syringe, Accessorized Prefilled Syringe, or Autoinjector: A Randomized Trial in Healthy Volunteers

Clinical Therapeutics - Tập 43 - Trang 142-155.e5 - 2021
Yanan Zheng1, Lubna Abuqayyas2, Ayman Megally3, Rainard Fuhr4, Kinga Sałapa5, John Downie6, Gene Colice3
1Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, South San Francisco, CA, USA
2Clinical Pharmacology Modeling and Simulation, Amgen, Cambridge, MA, USA
3Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
4Parexel International, Berlin, Germany
5Biometrics, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland
6Global Development Inflammation, Amgen, Thousand Oaks, CA, USA

Tài liệu tham khảo

Gauvreau, 2014, Effects of an anti-TSLP antibody on allergen-induced asthmatic responses, N Engl J Med, 370, 2102, 10.1056/NEJMoa1402895

Corren, 2017, Tezepelumab in adults with uncontrolled asthma, N Engl J Med, 377, 936, 10.1056/NEJMoa1704064

Takai, 2012, TSLP expression: cellular sources, triggers, and regulatory mechanisms, Allergol Int, 61, 3, 10.2332/allergolint.11-RAI-0395

Ziegler, 2013, The biology of thymic stromal lymphopoietin (TSLP), Adv Pharmacol, 66, 129, 10.1016/B978-0-12-404717-4.00004-4

Gauvreau, 2020, Thymic stromal lymphopoietin: its role and potential as a therapeutic target in asthma, Expert Opin Ther Targets, 1

Parnes, 2019, Pharmacokinetics, safety, and tolerability of tezepelumab (AMG 157) in healthy and atopic dermatitis adult subjects, Clin Pharmacol Ther, 106, 441, 10.1002/cpt.1401

Roseti, 2017, Pharmacokinetic and safety evaluation of tezepelumab in adolescents with mild to moderate asthma, Am J Respir Crit Care Med, 195, A5103

Sakamoto, 2020, A phase 1, randomized, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics, and immunogenicity of subcutaneous tezepelumab in healthy Japanese men, Clin Pharmacol Drug Dev, 9, 833, 10.1002/cpdd.775

2010

2019

2015

Struemper, 2016, Relative bioavailability of a single dose of belimumab administered subcutaneously by prefilled syringe or autoinjector in healthy subjects, Clin Pharmacol Drug Dev, 5, 208, 10.1002/cpdd.219

Martin, 2019, Comparison of autoinjector with accessorized prefilled syringe for benralizumab pharmacokinetic exposure: AMES trial results, J Asthma, 1

Xu, 2010, Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects, J Clin Pharmacol, 50, 276, 10.1177/0091270009340782

Ortega, 2014, Pharmacokinetics and absolute bioavailability of mepolizumab following administration at subcutaneous and intramuscular sites, Clin Pharmacol Drug Dev, 3, 57, 10.1002/cpdd.60

Wang, 2009, Fixed dosing versus body size-based dosing of monoclonal antibodies in adult clinical trials, J Clin Pharmacol, 49, 1012, 10.1177/0091270009337512

Dirks, 2010, Population pharmacokinetics of therapeutic monoclonal antibodies, Clin Pharmacokinet, 49, 633, 10.2165/11535960-000000000-00000

Genentech Inc. Xolair (omalizumab) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/omalgen062003LB.pdf. Accessed July 3, 2020.

GlaxoSmithKline. Nucala (mepolizumab) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125526Orig1s000Lbl.pdf. Accessed July 3, 2020.

AstraZeneca. Fasenra (benralizumab) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761070s000lbl.pdf. Accessed July 3, 2020.

Cohen, 2019, Decreased injection site pain associated with phosphate-free etanercept formulation in rheumatoid arthritis or psoriatic arthritis patients: a randomized controlled trial, Rheumatol Ther, 6, 245, 10.1007/s40744-019-0152-8

Sato, 2014, Pain assessment for subcutaneous injection of biologics in the treatment of rheumatoid arthritis, Clin Rheumatol Rel Res, 26, 121

Thông tin
Thông tin xuất bản

Clinical Therapeutics

Tập 43

142-155.e5

Thông tin tác giả